# Director — Wave 0/1 coordination log

Role: `flow-director` (research director/reconciler). This file records only Wave 0/1 coordination
activity — sent-message matrix and specialist replies. No synthesis, no numbered deliverables, no
`SOURCE_LEDGER.csv` here or elsewhere in this wave, per `CLAUDE.md` and `orchestration/ORCHESTRATION.md`.

Note on provenance: this session is background-isolated in git worktree `flow-director-wave0`
(branch `worktree-flow-director-wave0`) per harness policy for background sessions. This file is
committed/pushed from that worktree; it should be merged into the shared working tree alongside the
other specialists' lane files during Wave 3 reconciliation (each specialist appears to be working in
its own similarly isolated worktree — e.g. `ckm-combinations-lane`, `endocrinology-lane`,
`trialist-stats-lane` were already present under `.claude/worktrees/` at Wave 0 dispatch time).

## Context read before dispatch

- `CLAUDE.md` (project instructions / non-negotiable evidence rules / file contract)
- `Semaglutide ckd and flow evidence prompt.md` (master prompt)
- `research/semaglutide_ckd_flow/2026-09-05/orchestration/ORCHESTRATION.md` (roles, wave sequence, message protocol)
- `research/semaglutide_ckd_flow/2026-09-05/orchestration/SESSION_LOG.md` (session UUIDs, Wave 1 state = "launched" for all six specialists as of dispatch)
- `research/semaglutide_ckd_flow/2026-09-05/orchestration/prompts/01-06_*.md` (role prompts, headers only)

At dispatch time, `lanes/` was empty (no Wave 1 memos yet written) in the main checkout.

## Sent-message matrix (Wave 0 CROSS_SESSION_TEST)

| # | Recipient session | ListAgents ref | Owned Wave 1 path | msg_id | Sent | Reply received |
|---|---|---|---|---|---|---|
| 1 | `flow-source-librarian` | `e04063` | `lanes/01_source_librarian.md` | `a8e46a7f-adb3-4b0b-9b36-75681c43c8b0` | ✅ | ✅ received |
| 2 | `flow-trialist` | `31743f` | `lanes/02_trialist_statistics.md` | `198ca981-c96e-4ce2-854a-877fa59f112a` | ✅ | ✅ received |
| 3 | `flow-nephrologist` | `c77be6` | `lanes/03_nephrology.md` | `f33a377f-96b3-4994-994e-f386c2db0998` | ✅ | ✅ received |
| 4 | `flow-endocrinologist` | `5d09cb` | `lanes/04_endocrinology.md` | `142bdc1b-9946-48bb-b187-3d459fd26eea` | ✅ | ✅ received |
| 5 | `flow-ckm` | `be1796` | `lanes/05_ckm_combinations.md` | `b543368a-2c45-46cb-88e4-20ad5a4fc7ef` | ✅ | ✅ received |
| 6 | `flow-methodologist` | `b4cc2f` | `lanes/06_methods_mechanisms.md` | `8ec02c50-d55a-40ba-ab78-42d33ff7c99b` | ✅ | ⏳ pending |

Each message asked for: (1) READY confirmation against CLAUDE.md / master prompt / ORCHESTRATION.md / own role
prompt; (2) confirmation of owned Wave 1 output path (plus any role-prefixed `sources/retrieved/` notes);
(3) single highest-priority uncertainty or conflict so far. Each also instructed the specialist to resume/finish
its Wave 1 memo after replying, and reiterated the director-only restriction on numbered deliverables 01-16 and
`SOURCE_LEDGER.csv`. All six sessions showed `bg · busy` in `ListAgents` at send time, consistent with active
Wave 1 work already in progress.

## Replies log

### `flow-trialist` (received)

- **READY:** Yes — confirms reading CLAUDE.md, master prompt, ORCHESTRATION.md, role prompt
  `02_trialist_statistics.md`.
- **Path:** Confirmed `lanes/02_trialist_statistics.md`. No `sources/retrieved/` note planned yet (FLOW data
  taken from local fulltext); may add one later only if pulling CREDENCE/DAPA-CKD/EMPA-KIDNEY/FIDELIO primary
  numbers from the web for a contextual comparison table.
- **Highest-priority issue (data quality, not a numeric conflict):**
  `fulltext/FLOW_primary_NEJM_2024_fulltext.md` Table 2 (efficacy/safety outcomes table, journal p.116) is
  extracted as mirrored/character-reversed text — unusable as-is. Trialist self-resolved by reading
  `fulltext/FLOW.pdf` page 8 directly (image) and transcribing Table 2 cleanly. Flags for other lanes and the
  librarian: anyone quoting FLOW Table 2 component-level numbers (initiation of kidney-replacement therapy 87
  vs 100; persistent eGFR<15 92 vs 110; persistent ≥50% eGFR reduction 165 vs 213; death from kidney-related
  causes 5 vs 5) from the `.md` extraction should re-verify against the PDF page image rather than trust the
  `.md` for that table. No other numeric conflicts found yet.
- **Action for director:** relay this data-quality flag to `flow-source-librarian` (owns source
  inventory/fulltext integrity) so the ledger notes the Table 2 extraction defect and the correct-transcription
  values trialist already recovered — done below (see "Director actions this turn").

### `flow-endocrinologist` (received)

- **READY:** Yes — confirms reading CLAUDE.md, master prompt, ORCHESTRATION.md, role prompt
  `04_endocrinology.md`.
- **Path:** Confirmed `lanes/04_endocrinology.md`. No `sources/retrieved/` notes planned yet (citing primary
  journal articles inline with DOI/PMID); will add a role-prefixed note only if a source worth preserving
  verbatim turns up (e.g. paywalled abstract-only extraction).
- **Highest-priority uncertainty:** The SUSTAIN-6/LEADER pooled GLP-1RA kidney-mediation analysis (Mann et al.,
  *Diabetes Obes Metab* 2021, DOI 10.1111/dom.14443) reports HbA1c mediates ~25-26% and systolic BP ~9-22% of
  the kidney-composite effect — a meaningfully large mediated fraction that cuts against a strong
  "independent of glycemia/BP" claim for the pre-FLOW signal. Yet FLOW's own discussion (citing this same
  mediation work) argues effects were "unrelated to changes in body weight" and consistent whether eGFR is
  creatinine- or cystatin-C-based. No semaglutide-specific (vs pooled semaglutide+liraglutide) mediation
  breakdown found yet, and no FLOW-specific mediation analysis for HbA1c/weight/BP. Endocrinology lane will
  grade this as suggestive-at-best pre-FLOW and largely unknown/unquantified for FLOW itself pending a
  FLOW-specific mediation paper. Flags possible overlap with nephrology (03) and methods/mechanisms (06) lanes
  chasing the same source — risk of duplicated work or conflicting mediation-strength language at Wave 2.
- **Action for director:** relay this overlap flag to `flow-nephrologist` and `flow-methodologist` so they can
  coordinate on mediation-strength language before Wave 2 — done below (see "Director actions this turn"). This
  is directly relevant to CLAUDE.md rule 7 (no inferring causally independent glucose/weight/BP-mediated
  effects from subgroup consistency alone) — will need explicit attention at Wave 3 reconciliation.

### `flow-nephrologist` (received)

- **READY:** Yes — confirms reading CLAUDE.md, master prompt, ORCHESTRATION.md, role prompt
  `03_nephrology.md`. Also read the FLOW primary (NEJM 2024) fulltext + Supplementary Appendix in full, plus
  Mann 2024 (SGLT2i), Mahaffey 2025 (CV-by-CKD-severity), Rossing 2025 (MRA) fulltexts; skimmed Neuen 2024
  (modeled combination therapy) and Sawami 2024 (narrative review).
- **Path:** Confirmed `lanes/03_nephrology.md` only. No `sources/retrieved/` note planned yet (working from
  local `fulltext/`); will add a role-prefixed note only if pulling something not already local (e.g.
  eGFR<25/dialysis/non-diabetic-CKD claims).
- **Highest-priority uncertainty:** Independently hit the same FLOW Table 2 OCR-scramble that `flow-trialist`
  reported (columns/rows out of order, text reversed, roughly lines 480-850 of
  `fulltext/FLOW_primary_NEJM_2024_fulltext.md`). Can confidently confirm composite-level numbers (primary
  composite 331/410; kidney-specific 4-component composite HR 0.79 [0.66-0.94]; CV death alone HR 0.71
  [0.56-0.89]; CV death ≈35% of primary-composite events per Supplement Table S2 note) but declined to guess
  per-component n's from garbled OCR. Attempting a clean re-extraction from `fulltext/FLOW.pdf` Table 2
  (page ~116) directly; if unresolved will file an explicit GAP in the lane memo for the trialist to
  re-verify. **Cross-check:** this independently corroborates trialist's per-component numbers already
  relayed to the librarian (kidney-replacement therapy 87 vs 100; persistent eGFR<15 92 vs 110; persistent
  ≥50% eGFR reduction 165 vs 213; kidney death 5 vs 5) — two lanes now converge on the same PDF-page
  transcription route and the same composite-level figures, which is reassuring for those numbers.
- **Follow-up ack (after relay):** Nephrologist acknowledges the endocrinology mediation-analysis relay.
  FLOW's own Discussion (NEJM 2024;391:109, citing Mann et al. 2021 as ref 11) says kidney/CV risk-factor
  changes were "only modestly mediated" — not a body-weight-specific mediation analysis, and not
  FLOW-specific quantification. Nephrology will grade the "independent of glycemia/weight/BP" claim as
  suggestive-at-best / not formally quantified for FLOW itself in `lanes/03_nephrology.md`, consistent with
  CLAUDE.md rule 7, and will flag it explicitly as a cross-lane item for Wave 2 rather than asserting
  independence. No duplicate retrieval planned.

### `flow-ckm` (received)

- **READY:** Yes — confirms reading CLAUDE.md, master prompt, ORCHESTRATION.md, role prompt
  `05_ckm_combinations.md`.
- **Path:** Confirmed `lanes/05_ckm_combinations.md` only. Core evidence (FLOW primary NEJM+supplement, Mann
  2024 SGLT2i subgroup, Rossing 2025 MRA subgroup, Mahaffey 2025 CV-by-CKD-severity, Neuen 2024
  lifetime-modeling, Sawami 2024 review) already in `fulltext/`; supplementing with WebSearch/WebFetch for
  current guideline/regulatory items. Will add a `ckm`-role-prefixed retrieved note only if a new full source
  is pulled.
- **Highest-priority uncertainty:** Several 2026 current-source items could not be independently
  quote-verified this session because primary-document fetches were blocked (403 / undecompilable PDF):
  (1) **KDIGO 2026 Diabetes+CKD guideline** — corroborated via kdigo.org as a March 2026 public-review draft,
  comment period closed 2026-04-13; no confirmed final-publication date as of 2026-09-05 — treating as
  DRAFT-ONLY, not quoting exact recommendation text. (2) **ADA Standards of Care 2026 CKD chapter**
  (rec. 11.7b / 9.10-9.11) — content triangulated via secondary summaries only; exact wording NOT
  independently confirmed (diabetesjournals.org fetch blocked). (3) **2026 AHA/ACC/ADA/ASN CKM guideline** —
  confirmed published (JACC, DOI 10.1016/j.jacc.2026.03.056, June 9 2026) but exact sequencing/layering
  recommendation text for RASi+SGLT2i+finerenone+GLP-1RA not independently retrievable (fetch blocked). Will
  flag all three as unverified-wording (not asserting quotes) for the librarian/red-team to chase primary-text
  confirmation. No blocking numerical conflicts against other lanes yet (none had written memos at reply
  time).
- **Director note:** this is a verification-access gap, not a numeric conflict — appropriate for
  `flow-source-librarian` to track and for Wave 5 red-team to re-attempt with different fetch routes before
  any CKM-guideline-sequencing claim is finalized at Wave 3.

### `flow-source-librarian` (received)

- **READY:** Yes — confirms reading CLAUDE.md (including an on-disk update received mid-Wave-0 adding the
  `research_hub`/`paper-search`/`google-scholar` MCP preference, a no-Sci-Hub rule, and the
  `sources/retrieved/cache/` convention — see note below), the full master prompt, ORCHESTRATION.md, and role
  prompt `01_source_librarian.md`.
- **Path:** Confirmed `lanes/01_source_librarian.md` — **written and complete this turn** (source inventory
  table with stable IDs, claim-support mapping, exact local FLOW-number locators, draft `SOURCE_LEDGER.csv`
  row block, missing/inaccessible sources + bibliographic inconsistencies, review/editorial exclusion list,
  handoff summary). No `sources/retrieved/` notes added — no PDFs downloaded/cached this turn; web
  verification was bibliographic-only (paper-search MCP / CrossRef / PubMed / Europe PMC / WebSearch, no
  Sci-Hub). Incorporated the director's Table 2 OCR-scramble relay and the trialist's transcribed component
  counts into lane §5, attributed to `flow-trialist`/`flow-nephrologist` pending their own clean
  re-verification.
- **Highest-priority uncertainty:** `SELECT-FLOW-SOUL-POOLED-2026` (*Lancet Diabetes Endocrinol* 2026, DOI
  10.1016/S2213-8587(26)00134-8, "Effect of semaglutide on kidney outcomes in the SELECT, FLOW, and SOUL
  trials: a prespecified pooled analysis") — bibliographic identity (title/authors/DOI) confirmed verbatim via
  CrossRef and matches the master prompt, but abstract/results not retrievable this session (no volume/page
  yet, consistent with very recent online-first). Flagged as a master-prompt "high-priority current source"
  for Section V; librarian can vouch only for bibliographic identity, not the numbers — whoever owns that
  content (trialist or methodologist) should fetch full text before Wave 3.
- **Note on mid-Wave-0 CLAUDE.md update:** `CLAUDE.md` changed on disk after this director's Wave 0 dispatch,
  adding: MCP source-discovery preference (`research_hub`/`paper-search`/`google-scholar` first;
  `openevidence` orientation-only, never a primary-source substitute); an explicit no-Sci-Hub rule; a
  `sources/retrieved/cache/` (gitignored) convention for downloaded PDFs/parses, with only metadata/provenance/
  short notes going to the public repo; an API-key handling rule for the LlamaParse MCP; and `llamaparse`
  restricted to lawfully-obtained PDFs with route/license recorded. This session (director) is now working
  under the updated file. Flagging for the record since it postdates this director's original Wave 0
  dispatch messages — worth a quick note to any lane that already downloaded/cached a PDF before the update
  landed, to confirm its storage location and route documentation are compliant. Not treating this as
  something to "undo" — per system guidance, it's the current, deliberate state.

### `flow-trialist` (follow-up on `SELECT-FLOW-SOUL-POOLED-2026` relay)

- Declines ownership: lane `02_trialist_statistics` is scoped strictly to FLOW trial anatomy/endpoints/
  statistics per role brief; the SELECT/FLOW/SOUL pooled post-FLOW analysis is out of scope. Noted
  "outstanding, owned by flow-methodologist" in its lane file for reconciliation visibility. **Wave 1 lane
  memo (`lanes/02_trialist_statistics.md`) is now complete.**
- **Director action:** sent `flow-methodologist` a follow-up confirming sole ownership of
  `SELECT-FLOW-SOUL-POOLED-2026` by default — no further coordination needed with trialist on this item.

## Director actions this turn

1. Relayed `flow-trialist`'s FLOW Table 2 extraction-defect flag to `flow-source-librarian` (own the source
   inventory/fulltext integrity) with the corrected component-level numbers, so the ledger can note the
   `.md` extraction defect and point lane authors to the PDF page image. (`flow-nephrologist`'s independent
   corroboration of the same defect, received after the relay was sent, is noted above but not yet
   re-relayed — low priority since it confirms rather than changes the librarian's action item.)
2. Relayed `flow-endocrinologist`'s mediation-analysis overlap flag to `flow-nephrologist` and
   `flow-methodologist` so they can coordinate mediation-strength language ahead of Wave 2 and avoid
   duplicated retrieval of Mann et al. 2021 (DOI 10.1111/dom.14443). `flow-nephrologist` acknowledged and
   will grade consistently with CLAUDE.md rule 7 (see above).
3. Relayed `flow-source-librarian`'s `SELECT-FLOW-SOUL-POOLED-2026` fulltext gap (DOI
   10.1016/S2213-8587(26)00134-8 — bibliographic identity confirmed, results not yet retrieved) to both
   `flow-trialist` and `flow-methodologist`, asking them to coordinate so only one lane chases the full text
   before Wave 3 and the other notes it as outstanding/owned-by-peer.
4. After `flow-trialist` declined (out of scope) and named `flow-methodologist` as owner in its lane file,
   sent `flow-methodologist` a follow-up confirming sole ownership by default — closes the coordination loop
   on this item without director adjudication.

These are coordination relays only (naming exact files/sources per the ORCHESTRATION.md message protocol) —
no claim adjudication, no numbered-deliverable writing.

## Status / handoff

- **State:** All six Wave 0 CROSS_SESSION_TEST messages dispatched. 5/6 replies received
  (`flow-trialist`, `flow-endocrinologist`, `flow-nephrologist`, `flow-ckm`, `flow-source-librarian`), all
  READY=yes with confirmed paths — `flow-trialist` and `flow-source-librarian` both report their lane files
  (`lanes/02_trialist_statistics.md`, `lanes/01_source_librarian.md`) already written and complete. Four
  cross-lane-relevant items surfaced and relayed: (a) FLOW Table 2 OCR-scramble, independently corroborated
  by two lanes with converging composite-level numbers, now folded into the librarian's lane §5; (b) pre-FLOW
  glycemia/BP-mediation evidence vs FLOW's own "modestly mediated" language — nephrology and endocrinology
  aligned on grading it suggestive-at-best/unquantified per CLAUDE.md rule 7, methodologist still to weigh in;
  (c) three 2026 guideline/regulatory items CKM could not quote-verify (KDIGO 2026 draft, ADA 2026 CKD
  chapter, AHA/ACC/ADA/ASN CKM guideline sequencing text) — flagged as a verification-access gap for the
  librarian/red-team; (d) `SELECT-FLOW-SOUL-POOLED-2026` pooled-analysis fulltext — trialist declined
  (out of scope) and named methodologist as sole owner; director confirmed that assignment. 1/6 replies still
  pending (`flow-methodologist`, who now holds the original ask plus two relays — mediation-analysis overlap
  and confirmed sole ownership of the SELECT-FLOW-SOUL fulltext gap).
- **CLAUDE.md updated mid-Wave-0** (on disk, after this director's original dispatch): adds MCP
  source-discovery preference, no-Sci-Hub rule, `sources/retrieved/cache/` convention, and an API-key handling
  rule for LlamaParse. This session is operating under the updated file; flagged in the librarian reply entry
  above for visibility to any lane that cached a source before the update landed.
- **Next action for this (director) session:** on resume, capture `flow-methodologist`'s reply (and its
  responses to the two pending relays) below, watch for all six lane files landing before assigning Wave 2
  cross-examination pairs, and note any READY=no, path mismatch, or unresolved conflict that needs early
  attention.
- **Not yet done (by design, out of scope for Wave 0/1):** no numbered deliverables (01-16), no
  `SOURCE_LEDGER.csv`, no conflict resolution/adjudication, no synthesis. `12_EVIDENCE_GAPS_AND_CONTROVERSIES.md`
  and `15_CLAIM_EVIDENCE_MAP.md` remain for Wave 3 once all lane memos and Wave 2 cross-reviews exist.
- **Files written this turn:** this file only (`orchestration/DIRECTOR_WAVE0.md`, in worktree
  `flow-director-wave0`).
